Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -52.17%86.99M | -35.97%142.64M | -10.05%87.62M | 51.38%569.92M | -65.07%67.85M | 107.69%181.87M | 708.49%222.78M | -25.79%97.41M | -61.73%376.47M | -34.72%194.24M |
| Net income from continuing operations | -23.28%50.48M | 1,177.32%49.11M | 34.17%80.63M | -86.79%60.68M | -151.61%-69.05M | -45.05%65.79M | -96.21%3.85M | -42.43%60.09M | -24.87%459.31M | -46.48%133.78M |
| Operating gains losses | -189.02%-4.37M | -110.93%-2.71M | -310.89%-5.7M | 612.92%32.75M | 295.63%4.39M | 311.86%4.91M | 329.64%24.84M | -115.42%-1.39M | 34.12%-6.39M | -299.29%-2.24M |
| Depreciation and amortization | -9.31%47.77M | -15.71%47.95M | -3.47%50.42M | 11.09%215.77M | -6.66%53.98M | 7.90%52.67M | 24.67%56.88M | 24.50%52.23M | 30.05%194.23M | 30.94%57.83M |
| Asset impairment expenditure | --0 | --0 | ---- | -0.03%142.5M | 61.54%137.84M | --0 | -91.53%4.66M | ---- | 37.86%142.54M | 222.07%85.33M |
| Remuneration paid in stock | 248.89%11.9M | 12.24%6.48M | 184.94%2.09M | -95.19%1.46M | -19.87%6.15M | -272.21%-7.99M | -23.04%5.77M | -123.34%-2.46M | 58.74%30.36M | 50.44%7.67M |
| Deferred tax | -112.05%-4.04M | -99.54%378K | -123.80%-8.81M | 198.41%158.2M | 105.23%4.75M | 288.48%33.5M | 282.45%82.95M | 649.64%37.01M | -4.22%-160.75M | 62.24%-90.78M |
| Other non cashItems | 22.93%3.56M | 80.50%3.62M | 17.20%3.31M | 28.17%10.87M | 75.85%3.14M | 13.84%2.9M | 28.36%2.01M | 9.24%2.83M | 51.94%8.48M | 270.33%1.79M |
| Change In working capital | -160.82%-18.31M | -9.58%37.82M | 32.56%-34.32M | 82.04%-52.32M | -8,580.23%-73.35M | 142.84%30.1M | 121.85%41.83M | -67.14%-50.9M | -212.60%-291.31M | -99.59%865K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -52.17%86.99M | -35.97%142.64M | -10.05%87.62M | 51.38%569.92M | -65.07%67.85M | 107.69%181.87M | 708.49%222.78M | -25.79%97.41M | -61.73%376.47M | -34.72%194.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 17.94%-74.42M | 41.25%-59.14M | 35.66%-63.02M | 26.75%-392.24M | 17.68%-102.96M | 32.33%-90.69M | 34.81%-100.66M | 19.72%-97.94M | 16.08%-535.52M | 39.76%-125.07M |
| Capital expenditure reported | 7.52%-57.42M | 23.09%-45.4M | 9.78%-40.3M | 35.49%-226.02M | -20.73%-60.23M | 33.65%-62.09M | 43.19%-59.03M | 56.62%-44.67M | 33.92%-350.36M | 70.29%-49.89M |
| Net PPE purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net business purchase and sale | --0 | ---- | ---15.97M | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Net other investing changes | 40.56%-17M | 67.00%-13.74M | 87.34%-6.74M | 10.23%-166.22M | 43.17%-42.73M | 29.27%-28.6M | 17.59%-41.63M | -180.17%-53.26M | -71.67%-185.15M | -89.43%-75.19M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 17.94%-74.42M | 41.25%-59.14M | 35.66%-63.02M | 26.75%-392.24M | 17.68%-102.96M | 32.33%-90.69M | 34.81%-100.66M | 19.72%-97.94M | 16.08%-535.52M | 39.76%-125.07M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 38.35%-42.53M | -13.05%-67.09M | 43.30%-41.79M | -64.51%-214.9M | -133.76%-12.86M | -30.67%-68.98M | -7.50%-59.35M | -21.38%-73.71M | 55.26%-130.63M | 287.89%38.09M |
| Net issuance payments of debt | 59.50%-8.18M | -215.88%-32.17M | 65.92%-10.29M | -134.36%-30.68M | -66.73%29.88M | -10,869.57%-20.18M | -5,787.28%-10.19M | -17,661.18%-30.19M | 13,134.74%89.29M | 53,881.44%89.82M |
| Net common stock issuance | 63.30%-7.61M | 71.80%-6.03M | 65.74%-5.24M | 29.77%-73.79M | 26.92%-16.41M | 14.63%-20.72M | 16.12%-21.37M | 53.48%-15.29M | 52.56%-105.07M | ---22.45M |
| Cash dividends paid | 5.53%-26.89M | 3.39%-27.56M | 7.59%-26.37M | 5.47%-112.18M | 9.65%-26.66M | 2.64%-28.47M | 5.23%-28.53M | 4.36%-28.53M | -57.21%-118.68M | -46.73%-29.51M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -91.93%309K | --0 | --0 | --0 | -85.58%309K | -32.39%3.83M | --237K |
| Net other financing activities | -62.85%146K | -281.58%-1.33M | --103K | --1.45M | --323K | --393K | --733K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 38.35%-42.53M | -13.05%-67.09M | 43.30%-41.79M | -64.51%-214.9M | -133.76%-12.86M | -30.67%-68.98M | -7.50%-59.35M | -21.38%-73.71M | 55.26%-130.63M | 287.89%38.09M |
| Net cash flow | ||||||||||
| Beginning cash position | -20.04%103.5M | 24.00%86.16M | -29.27%101.79M | -65.65%143.91M | 338.66%151.55M | -2.95%129.44M | -81.34%69.48M | -65.65%143.91M | 10.75%419M | -90.21%34.55M |
| Current changes in cash | -234.89%-29.95M | -73.85%16.42M | 76.85%-17.18M | 87.15%-37.22M | -144.72%-47.97M | 122.37%22.21M | 125.49%62.77M | -44.27%-74.23M | -641.23%-289.67M | 53.94%107.26M |
| Effect of exchange rate changes | 1,433.70%1.23M | 132.93%928K | 896.92%1.55M | -133.59%-4.9M | -185.50%-1.79M | -122.12%-92K | -139.17%-2.82M | -104.00%-195K | 213.39%14.58M | 156.65%2.1M |
| End cash Position | -50.66%74.78M | -20.04%103.5M | 24.00%86.16M | -29.27%101.79M | -29.27%101.79M | 338.66%151.55M | -2.95%129.44M | -81.34%69.48M | -65.65%143.91M | -65.65%143.91M |
| Free cash from | -75.31%29.58M | -40.62%97.24M | -10.28%47.32M | 1,217.19%343.89M | -94.72%7.62M | 2,091.45%119.79M | 216.54%163.75M | 86.47%52.74M | -94.24%26.11M | 11.35%144.36M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.